These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23232068)

  • 1. Kinetic studies of inhibition of the amyloid beta (1-42) aggregation using a ferrocene-tagged β-sheet breaker peptide.
    Zhang L; Yagnik G; Peng Y; Wang J; Xu HH; Hao Y; Liu YN; Zhou F
    Anal Biochem; 2013 Mar; 434(2):292-9. PubMed ID: 23232068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.
    Zhou B; Li CL; Hao YQ; Johnny MC; Liu YN; Li J
    Bioorg Med Chem; 2013 Jan; 21(2):395-402. PubMed ID: 23245572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of aggregation of amyloid peptides by beta-sheet breaker peptides and their binding affinity.
    Viet MH; Ngo ST; Lam NS; Li MS
    J Phys Chem B; 2011 Jun; 115(22):7433-46. PubMed ID: 21563780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of possible binding sequences of two beta-sheet breaker peptides on beta amyloid peptide of Alzheimer's disease.
    Hetényi C; Körtvélyesi T; Penke B
    Bioorg Med Chem; 2002 May; 10(5):1587-93. PubMed ID: 11886820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of fibril formation by a beta-sheet breaker peptide ligand: an electrochemical approach.
    Veloso AJ; Kerman K
    Bioelectrochemistry; 2012 Apr; 84():49-52. PubMed ID: 21967982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Cu-amyloid-β by using bifunctional peptides with β-sheet breaker and chelator moieties.
    Jensen M; Canning A; Chiha S; Bouquerel P; Pedersen JT; Østergaard J; Cuvillier O; Sasaki I; Hureau C; Faller P
    Chemistry; 2012 Apr; 18(16):4836-9. PubMed ID: 22422637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation pathways of the amyloid β(1-42) peptide depend on its colloidal stability and ordered β-sheet stacking.
    Jiang D; Rauda I; Han S; Chen S; Zhou F
    Langmuir; 2012 Sep; 28(35):12711-21. PubMed ID: 22870885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of accelerated assembly of beta-amyloid filaments into fibrils by KLVFFK(6).
    Kim JR; Murphy RM
    Biophys J; 2004 May; 86(5):3194-203. PubMed ID: 15111432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-situ side-chain peptide cyclization as a breaker strategy against the amyloid aggregating peptide.
    Ghosh N; Kundu LM
    Bioorg Med Chem; 2021 Mar; 33():116017. PubMed ID: 33486160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferrocene-modified peptides as inhibitors against insulin amyloid aggregation based on molecular simulation.
    Yao P; Zhang J; You S; Qi W; Su R; He Z
    J Mater Chem B; 2020 Apr; 8(15):3076-3086. PubMed ID: 32202581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Amyloid β-Protein (Aβ) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting Aβ Toxicity.
    Li H; Rahimi F; Bitan G
    ACS Chem Neurosci; 2016 Jul; 7(7):845-56. PubMed ID: 27322435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin-derived peptides as β-amyloid inhibitors.
    Cho PY; Joshi G; Johnson JA; Murphy RM
    ACS Chem Neurosci; 2014 Jul; 5(7):542-51. PubMed ID: 24689444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The iAβ5p β-breaker peptide regulates the Aβ(25-35) interaction with lipid bilayers through a cholesterol-mediated mechanism.
    Vitiello G; Grimaldi M; D'Ursi AM; D'Errico G
    Biochem Biophys Res Commun; 2012 Jan; 417(1):88-92. PubMed ID: 22138241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.
    Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of peptide inhibitors of soluble Aβ(1-42) oligomer formation by phage display.
    Kawasaki T; Onodera K; Kamijo S
    Biosci Biotechnol Biochem; 2010; 74(11):2214-9. PubMed ID: 21071869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of aggregation using β-breaker dipeptide containing peptides: Application to Aβ(1-40) self-assembly and its inhibition.
    Nadimpally KC; Paul A; Mandal B
    ACS Chem Neurosci; 2014 May; 5(5):400-8. PubMed ID: 24661180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NABi, a novel β-sheet breaker, inhibits Aβ aggregation and neuronal toxicity: Therapeutic implications for Alzheimer's disease.
    Jang JY; Rhim H; Kang S
    Biochim Biophys Acta Gen Subj; 2018 Jan; 1862(1):71-80. PubMed ID: 29107146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Alzheimer's amyloid-β peptide aggregation and its disruption by a conformationally restricted α/β hybrid peptide.
    Paul A; Nadimpally KC; Mondal T; Thalluri K; Mandal B
    Chem Commun (Camb); 2015 Feb; 51(12):2245-8. PubMed ID: 25514992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemical "signal-on" reporter for amyloid aggregates.
    Beheshti S; Martić S; Kraatz HB
    Chemphyschem; 2012 Feb; 13(2):542-8. PubMed ID: 22162023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.